ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

OPTH vs BFRI // FREE CASH FLOW YIELD

Optimi Health Corp. (NASDAQ) VS. Biofrontera Inc. (NASDAQ) • 15-METRIC TALLY: OPTH 1 — BFRI 1
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (OPTH VS. BFRI) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC OPTH BFRI SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin — — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) — -35.00% — TIE /roic <GO>
EV/EBITDA & P/E Valuation — — — TIE /valuation <GO>
Free Cash Flow Yield ACTIVE — — — TIE /fcf-yield <GO>
Operating Margin — -27.20% — TIE /operating-margins <GO>
Net Profit Margin — -25.30% — TIE /net-margins <GO>
Revenue Growth (YoY) — 11.70% — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality — 3/9 — TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 18.3 42.2 -23.90 BFRI /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $14.9M $13.8M $1.1M OPTH /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR OPTH REV BFRI REV OPTH GROSS % BFRI GROSS % OPTH FCF BFRI FCF
FY 2025 — $41.7M — — — -$13.4M
FY 2024 — $37.3M — — — -$10.3M
FY 2023 — $34.1M — — — -$24.9M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
OPTH // BETA —
BFRI // BETA —